2 unknown, 1 not yet recruiting, 1 recruiting. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 2, Not yet recruiting 1, Recruiting 1 |
Follow TP protocol: new trials by email Literature Review of TP protocol trials Research Report on TP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. Efbemalenograstim alfa Injection, carboplatin/cisplatin-etoposide, Carboplatin plus Paclitaxel - Solid Tumor Cancer, Chemotherapy Induced Neutropenia | Not applicable | Not yet recruiting | Shandong Cancer Hospital and Institute | 200 | 2024-10-10 | 2024-10-18 |
| The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer CCRT, Paclitaxel, Cisplatin - Cervical Cancer | Not applicable | Recruiting | Chongqing University Cancer Hospital | 120 | 2020-05-26 | 2023-04-11 |
| A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity. The concurrent 3 weeks TP regimen, The concurrent weekly TP regimen, External radiation plus intraluminal after-loading irradiation - Cervical Cancer | Not applicable | Unknown | Chongqing University Cancer Hospital | 200 | 2016-01-01 | 2020-10-19 |
| Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients Nimotuzumab and TP regimen, TP regimen - Non-small Cell Lung Cancer | Not applicable | Unknown | Tianjin Medical University Cancer Institute and Hospital | 160 | 2011-03-01 | 2016-02-17 |
Uterine Cervical Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1)
Chongqing University Cancer Hospital (2) · Shandong Cancer Hospital and Institute (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (4)
Daliang Qi, Master (1) · Dongling Zou, M.D. (1) · JinMing Yu, Phd (1)